Cell competition in development, homeostasis and cancer
SM van Neerven, L Vermeulen - Nature Reviews Molecular Cell …, 2023 - nature.com
Organ development and homeostasis involve dynamic interactions between individual cells
that collectively regulate tissue architecture and function. To ensure the highest tissue …
that collectively regulate tissue architecture and function. To ensure the highest tissue …
[HTML][HTML] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance
J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
Amino acids and their transporters in T cell immunity and cancer therapy
W Wang, W Zou - Molecular cell, 2020 - cell.com
Metabolism reprogramming is critical for both cancer progression and effective immune
responses in the tumor microenvironment. Amino acid metabolism in different cells and their …
responses in the tumor microenvironment. Amino acid metabolism in different cells and their …
Stem cell fate in cancer growth, progression and therapy resistance
Although we have come a long way in our understanding of the signals that drive cancer
growth, and how these signals can be targeted, effective control of this disease remains a …
growth, and how these signals can be targeted, effective control of this disease remains a …
Leukaemia: a model metastatic disease
AE Whiteley, TT Price, G Cantelli, DA Sipkins - Nature Reviews Cancer, 2021 - nature.com
In contrast to solid cancers, which often require genetic modifications and complex cellular
reprogramming for effective metastatic dissemination, leukaemic cells uniquely possess the …
reprogramming for effective metastatic dissemination, leukaemic cells uniquely possess the …
The bone-marrow niche in MDS and MGUS: implications for AML and MM
IM Ghobrial, A Detappe, KC Anderson… - Nature reviews Clinical …, 2018 - nature.com
Several haematological malignancies, including multiple myeloma (MM) and acute myeloid
leukaemia (AML), have well-defined precursor states that precede the development of overt …
leukaemia (AML), have well-defined precursor states that precede the development of overt …
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
Y Lee, P Wiriyasermkul, C Jin, L Quan… - Nature structural & …, 2019 - nature.com
The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
Stem cells in cancer initiation and progression
J Bajaj, E Diaz, T Reya - Journal of Cell Biology, 2019 - rupress.org
While standard therapies can lead to an initial remission of aggressive cancers, they are
often only a transient solution. The resistance and relapse that follows is driven by tumor …
often only a transient solution. The resistance and relapse that follows is driven by tumor …
SLC3A2 promotes tumor‐associated macrophage polarization through metabolic reprogramming in lung cancer
Tumor‐associated macrophages (TAMs) are one of the most abundant immunosuppressive
cells in the tumor microenvironment and possess crucial functions in facilitating tumor …
cells in the tumor microenvironment and possess crucial functions in facilitating tumor …
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting
Y Chen, J Li, L Xu, MA Găman, Z Zou - Cell Death Discovery, 2022 - nature.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by cytogenetic
and genomic alterations. Up to now, combination chemotherapy remains the standard …
and genomic alterations. Up to now, combination chemotherapy remains the standard …